NM_001081.4:c.4459C>T
Variant summary
Our verdict is Pathogenic. The variant received 16 ACMG points: 16P and 0B. PVS1PP5_Very_Strong
The NM_001081.4(CUBN):c.4459C>T(p.Arg1487*) variant causes a stop gained change. The variant allele was found at a frequency of 0.0000998 in 1,614,008 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. R1487R) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_001081.4 stop_gained
Scores
Clinical Significance
Conservation
Publications
- Imerslund-Grasbeck syndrome type 1Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Laboratory for Molecular Medicine
- proteinuria, chronic benignInheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- Imerslund-Grasbeck syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 16 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000986 AC: 15AN: 152120Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000358 AC: 9AN: 251470 AF XY: 0.0000368 show subpopulations
GnomAD4 exome AF: 0.0000999 AC: 146AN: 1461888Hom.: 1 Cov.: 32 AF XY: 0.0000963 AC XY: 70AN XY: 727244 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000986 AC: 15AN: 152120Hom.: 0 Cov.: 32 AF XY: 0.000135 AC XY: 10AN XY: 74288 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Imerslund-Grasbeck syndrome Pathogenic:2
This sequence change creates a premature translational stop signal (p.Arg1487*) in the CUBN gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CUBN are known to be pathogenic (PMID: 15024727, 22929189, 25349199, 31613795, 34979989). This variant is present in population databases (rs145661597, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with CUBN-related conditions. ClinVar contains an entry for this variant (Variation ID: 575738). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. -
- -
Imerslund-Grasbeck syndrome type 1;C5394384:Proteinuria, chronic benign Pathogenic:1
- -
Imerslund-Grasbeck syndrome type 1 Pathogenic:1
- -
not provided Pathogenic:1
Reported with a second variant (phase unknown) in a patient with renal disease in published literature (PMID: 31613795); Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 31613795, 25635822) -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at